Page last updated: 2024-08-23

1-methyl-4-phenylpyridinium and Brain Disorders

1-methyl-4-phenylpyridinium has been researched along with Brain Disorders in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cano, J; Machado, A; Santiago, M1
Budai, G; Kardos, V; Pátfalusi, M; Patthy, M; Sziráki, I1
Mizuno, Y; Mochizuki, H; Mori, H1
Flint Beal, M; Klivenyi, P; Oberley, T; St Clair, D; Wermer, M; Yang, L; Yen, HC1
Bradbury, AJ; Costall, B; Domeney, AM; Jenner, PG; Marsden, CD; Naylor, RJ; Testa, B1

Other Studies

5 other study(ies) available for 1-methyl-4-phenylpyridinium and Brain Disorders

ArticleYear
Effect of L-arginine/nitric oxide pathway on MPP(+)-induced cell injury in the striatum of rats.
    British journal of pharmacology, 1994, Volume: 111, Issue:3

    Topics: 1-Methyl-4-phenylpyridinium; Animals; Arginine; Brain Diseases; Corpus Striatum; Dialysis; Dopamine; Male; Nitric Oxide; Nitroarginine; Perfusion; Rats; Rats, Wistar; Time Factors

1994
Methamphetamine protects against MPTP neurotoxicity in C57BL mice.
    European journal of pharmacology, 1994, Jan-14, Volume: 251, Issue:2-3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Amphetamine; Animals; Brain Diseases; Corpus Striatum; Dopamine; Male; Methamphetamine; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neurons

1994
Apoptosis in neurodegenerative disorders.
    Journal of neural transmission. Supplementum, 1997, Volume: 50

    Topics: 1-Methyl-4-phenylpyridinium; Adult; Age of Onset; Aged; Aged, 80 and over; Animals; Apoptosis; Biomarkers; Brain Diseases; Coculture Techniques; DNA; DNA Nucleotidylexotransferase; Embryo, Mammalian; Humans; Melanins; Mesencephalon; Middle Aged; Neostriatum; Nerve Degeneration; Neurons; Parkinson Disease; Rats; Substantia Nigra; Tyrosine 3-Monooxygenase

1997
Manganese superoxide dismutase overexpression attenuates MPTP toxicity.
    Neurobiology of disease, 1998, Volume: 5, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Diseases; Cerebral Cortex; Dopamine; Dopamine Agents; Gene Expression; Humans; Mice; Mice, Transgenic; Microscopy, Immunoelectron; Mitochondria; Neurons; Superoxide Dismutase; Transgenes

1998
The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
    Neuroscience letters, 1985, Oct-24, Volume: 61, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Diseases; Chemical Phenomena; Chemistry; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Movement Disorders; Norepinephrine; Pyridines; Pyridinium Compounds; Rats; Serotonin; Substantia Nigra

1985